U.S. approves new drug for advanced breast cancer
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the U.SFood and Drug Administration on Thursday approved a new drug for advanced breast cancer, Tykerb, to be marketed, which will provide a new type of targeted therapy for patients with advanced breast cancerDeveloped by GlaxoSmithKline, it is a new type of targeted anti-cancer drugThe so-called targeted therapeutic drugs, refers to certain receptor,genes or key proteins as targets,and then targeted to kill the relevanttumorscells of the drug,the drug is used with another breast cancer treatment, Heroda,
effectively control advanced metastatic HER2-positive breast cancer, the FDA said The combination of two drugs is intended for patients who have previously taken other drugs but have metastasized breast cancer after treatment has not worked , Tykerb is a kinase inhibitor , it is unique in that it works in a variety of ways so that breast cancer cells do not receive the signals needed to grow, the FDA said According to the American Cancer Society, 180,000 new breast cancer cases are diagnosed in the United States each year, and about 8,000 to 10,000 women die each year of metastatic HER 2 positive breast cancer (
Xinhua News Agency, without permission, it is strictly prohibited to reproduce)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
